An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications

Yonsei Medical Journal

Volumn 46, Issue 3, 2005, Pages 425-430

  Bang, Seungmin ^a   Cheong, June Won ^a   Yang, Woo Ick ^a   Hahn, Jee Sook ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Hodgkin's disease; Incomplete chemotherapy; Spontaneous remission

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; BLEOMYCIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; GANCICLOVIR; PENTAMIDINE; PREDNISONE; PROCARBAZINE; SULPERAZON; VINBLASTINE; VINCRISTINE;

ADULT; ARTIFICIAL VENTILATION; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DRUG DOSE REGIMEN; DRUG SUBSTITUTION; DYSPNEA; FOLLOW UP; HODGKIN DISEASE; HUMAN; INFECTIOUS COMPLICATION; INTENSIVE CARE UNIT; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LUNG FUNCTION TEST; LYMPH NODE BIOPSY; MALE; NEPHROGENIC DIABETES INSIPIDUS; PANCREATITIS; PERONEAL NEUROPATHY; PERONEUS NERVE PARALYSIS; POSITRON EMISSION TOMOGRAPHY; REVIEW; TREATMENT OUTCOME; WHOLE BODY TOMOGRAPHY;

EID: 21844434427     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2005.46.3.425     Document Type: Review

References (22)

1. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966;26:1189-200.
2. Papac RJ. Spontaneous regression of cancer. Cancer Treat Rev 1996;22:395-423.
3. Challis GB, Stam HJ. The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol 1990;5:545-9.
4. Gattiker HH, Wiltshaw E, Galton DA. Spontaneous regression in non-Hodgkin's lymphoma. Cancer 1980; 45:2627-32.
5. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 1984;311:1471-5.
6. Krikorian JG, Portlock CS, Cooney P, Rosenberg SA. Spontaneous regression of non-Hodgkin's lymphoma: a report of nine cases. Cancer 1980;46:2093-9.
7. Poppema S, Postma L, Brinker M, de Jong B. Spontaneous regression of a small non-cleaved cell malignant lymphoma (non-Burkitt's lymphoblastic lymphoma). Morphologic, immunohistological, and immunoglobulin gene analysis. Cancer 1988;62:791-4.
8. Kumamoto M, Nakamine H, Hara T, Yokoya Y, Kawai J, Ito H, et al. Spontaneous complete regression of high grade non-Hodgkin's lymphoma. Morphologic, immunohistochemical, and gene amplification analyses. Cancer 1994;74:3023-8.
9. Heibel H, Knodgen R, Bredenfeld H, Wickenhauser C, Scheer M, Zoller JE. Complete spontaneous remission of an aggressive non-Hodgkin's lymphoma with primary manifestation in the oral cavity. Leuk Lymphoma 2004;45:1714.
10. Weinshel EL, Peterson BA. Hodgkin's disease. CA Cancer J Clin 1993;43:327-46.
11. Mangel J, Barth D, Berinstein NL, Imrie KR. Spontaneous regression of Hodgkin's disease: two case reports and a review of the literature. Hematology 2003;8:191-6.
12. Williams MV. Spontaneous regression of cutaneous Hodgkin's disease. Br Med J 1980;280:903.
13. Szur L, Harrison CV, Levene GM, Samman PD. Primary cutaneous Hodgkin's disease. Lancet 1970;1:1016-20.
14. Taqi AM, Abdurrahman MB, Yakubu AM, Fleming AF. Regression of Hodgkin's disease after measles. Lancet 1981;1:1112.
15. Zygiert Z. Hodgkin's disease: remissions after measles. Lancet 1971;1:593.
16. Parekh S, Koduri PR. Spontaneous regression of HIV-associated Hodgkin's disease. Am J Hematol 2003;72: 153-4.
17. Drobyski WR, Qazi R. Spontaneous regression in non-Hodgkin's lymphoma: clinical and pathogenetic considerations. Am J Hematol 1989;31:138-41.
18. Ono K, Kikuchi M, Funai N, Matsuzaki M, Shimamoto Y. Natural killing activity in patients with spontaneous regression of malignant lymphoma. J Clin Immunol 1996;16:334-9.
19. Loren AW, Porter DL, Stadtmauer EA, Tsai DE. Posttransplant lymphoproliferative disorder: a review. Bone Marrow Transplant 2003;31:145-55.
20. Ryu HJ, Hahn JS, Kim YS, Park K, Yang WI, Lee JD. Complete resolution of posttransplant lymphoproliferative disorder (diffuse large B-cell lymphoma) with reduction of immunosuppressive therapy. Yonsei Med J 2004;45:527-32.
21. Nauts H. The treatment of malignant tumors by bacterial toxins, as developed by the late William B. and Coley M.D. reviewed in the light of modern research. Cancer Res 1946;6:205-16
22. Balkwill FR, Naylor MS, Malik S. Tumour necrosis factor as an anticancer agent. Eur J Cancer 1990;26:641-4.